Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Not Randomised, Non-interventional, Postmarket Clinical Follow-Up (PMCF) Study on the Performance / Safety of Arcadius XP L® Interbody Fusion Device

NCT05944081 is registered in ClinicalTrials.gov with Aesculap AG as lead sponsor.

NCT NCT05944081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05944081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Not Randomised, Non-interventional, Postmarket Clinical Follow-Up (PMCF) Study on the Performance / Safety of Arcadius XP L® Interbody Fusion Device
Lead sponsor
Aesculap AG
Phase
Observational
Overall status
Withdrawn
Start date
March 15, 2024
Completion date
December 12, 2025
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic low-back pain, degenerative disc disease, postdiscectomy syndrome, posttraumatic instability, spondylolysis lumbar